Zoetis Inc (ZTS)
169.21
+0.70
(+0.42%)
USD |
NYSE |
Mar 28, 16:00
170.28
+1.07
(+0.63%)
Pre-Market: 20:00
Zoetis Total Assets (Quarterly): 14.29B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.29B |
September 30, 2023 | 14.11B |
June 30, 2023 | 13.75B |
March 31, 2023 | 13.75B |
December 31, 2022 | 14.92B |
September 30, 2022 | 13.67B |
June 30, 2022 | 13.77B |
March 31, 2022 | 13.86B |
December 31, 2021 | 13.90B |
September 30, 2021 | 13.70B |
June 30, 2021 | 14.07B |
March 31, 2021 | 13.80B |
December 31, 2020 | 13.61B |
September 30, 2020 | 13.72B |
June 30, 2020 | 13.07B |
March 31, 2020 | 11.53B |
December 31, 2019 | 11.54B |
September 30, 2019 | 11.27B |
June 30, 2019 | 10.99B |
March 31, 2019 | 10.88B |
December 31, 2018 | 10.78B |
September 30, 2018 | 10.46B |
June 30, 2018 | 8.603B |
March 31, 2018 | 8.69B |
December 31, 2017 | 8.586B |
Date | Value |
---|---|
September 30, 2017 | 9.288B |
June 30, 2017 | 7.802B |
March 31, 2017 | 7.649B |
December 31, 2016 | 7.649B |
September 30, 2016 | 7.715B |
June 30, 2016 | 7.518B |
March 31, 2016 | 7.453B |
December 31, 2015 | 7.913B |
September 30, 2015 | 6.686B |
June 30, 2015 | 6.598B |
March 31, 2015 | 6.43B |
December 31, 2014 | 6.588B |
September 30, 2014 | 6.527B |
June 30, 2014 | 6.522B |
March 31, 2014 | 6.403B |
December 31, 2013 | 6.558B |
September 30, 2013 | 6.259B |
June 30, 2013 | 6.261B |
March 31, 2013 | 6.142B |
December 31, 2012 | 6.262B |
September 30, 2012 | 5.904B |
June 30, 2012 | 5.80B |
March 31, 2012 | 5.906B |
December 31, 2011 | 5.711B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.88B
Minimum
Mar 2019
14.92B
Maximum
Dec 2022
13.21B
Average
13.74B
Median
Total Assets (Quarterly) Benchmarks
Biogen Inc | 26.84B |
Eli Lilly and Co | 64.01B |
Pfizer Inc | 226.50B |
Bristol-Myers Squibb Co | 95.16B |
Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 9.295B |
Shareholders Equity (Quarterly) | 4.997B |
Debt to Equity Ratio | 1.314 |
Current Ratio | 3.358 |
Net Debt Paydown Yield | -0.00% |